Lipum AB

Lipum develops an anti-inflammatory drug with first-in-class potential and we aim for better quality of life for the millions suffering from chronic inflammatory diseases, also children. Distressed by pain, disability, and comorbidities many have to leave a normal working life in advance. We intend to increase their quality of life and decrease the considerable health care and societal costs.


Contact:
Einar Pontén, CEO

Contact details
Tvistevägen 48C, SE-907 36 Umeå
Phone: +46 90 340 34 30